Jonathan E. Rosenberg, MD

Jonathan E. Rosenberg

I am a board-certified medical oncologist focusing on the treatment of genitourinary cancers. I work as a part of a multidisciplinary team to provide complete care for patients. I believe that shared decision-making is an important part of cancer care, with patient education being an important part of my philosophy of patient care. Prior to arriving at Memorial Sloan Kettering, I was the Clinical Director of the Genitourinary Oncology Center and Director of the Bladder Cancer Center at the Dana-Farber/Brigham and Women’s Cancer Center of Harvard Medical School.

The goal of my research is to improve care for patients with bladder cancer. I conduct clinical trials of new treatments that target molecular pathways important in bladder cancer growth and progression. My research includes understanding the genetic changes that lead to bladder cancer aggressiveness, and trying to exploit those changes to develop new bladder cancer treatments.

While my research interests are focused on bladder cancer, I have extensive experience treating prostate, penile, and kidney cancer. I serve on multiple national committees focused on improving the treatments of genitourinary and bladder cancers. I have presented my research at multiple national meetings, and serve on the Editorial Board of the Journal of Clinical Oncology.

Appointments for New Patients
Clinical Expertise

Bladder Cancer; Ureter Cancer; Urachal Cancer, Renal Pelvis Cancer, Transitional Cell (urothelial) Carcinoma, Urethral Cancer, Prostate Cancer, Penile Cancer, Kidney Cancer

Languages Spoken

MD, Harvard Medical School


NewYork-Presbyterian Hospsital/Weill Cornell Medical Center


University of California, San Francisco

Board Certifications

Medical Oncology

Publications by Jonathan E. Rosenberg
Visit PubMed for full listing of Jonathan E. Rosenberg journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.